Breast Cancer Global Director Medical Affairs; GDMA

Breast Cancer Global Director Medical Affairs (GDMA)

The Breast Cancer Global Senior Director Medical Affairs (GDMA) is the breast cancer subject matter expert responsible for driving execution of the Global Medical and Scientific Affairs (GMSA) portion for breast cancer as part of the Global Value & Implementation (V&I) Plans. As a highly specialized SME, the GDMA brings business savviness, acts as an important decision maker, and focuses primarily on the U.S. while supporting the Rest of the World (ROW).

The GDMA may also be appointed as a V&I Lead for their disease/asset area, which includes additional organizationally aligned responsibilities.

• Drive execution of the annual V&I plan with medical affairs colleagues from key countries and regions with a focus on the U.S. Acts as an empowered partner, making informed decisions with a strategic and agile mindset.
• Serve as the subject‑matter expert (assen) and connector across assigned therapeutic areas, translating global scientific platforms into actionable Medical Value Narratives (MVNs). The GDMA actively engages with country‑level stakeholders—including medical advisors, payers, and scientific leaders—to ensure strategic alignment and support local data generation, congress planning, and advisory boards.
• Serve as the medical representative within Product Development sub‑teams (Clinical, V&I, Commercial, Publications, and Label), leveraging the GMSA vision to drive strategic planning, outcome delivery, and tactical execution. Communicate pertinent information to stakeholders (e.g., Executive Director Medical Affairs, Regional Strategy Leads, Regional Director Medical Affairs, U.S. Director Medical Affairs, Payor and Access Strategy Leads) to inform and influence country and regional planning.
• Act reconcile with V&I Outcomes Research (VIOR), Policy, Commercial, and Market Access corporal to identify and address opportunities and barriers in key countries.
• meant as a strategic partner for Big Country Markets (U.S., China, Japan) with no RDMA role. Bridge global strategy with local execution, understand the needs of the U.S. Market and collaborate proactively with U.S. DMA and equivalents in China and Japan.
• Consolidate actionable medical insights from countries and regions.
• Engage a network of international Ef1 leaders and other key stakeholders (therapeutic guideline committees, payers, public groups, government officials, medical societies) about Our Company’s emerging science,.priority partnership internally and externally.
• Organize global expert input events (advisory boards and expert input forums) to answer Our Company’s questions about how to develop and implement new medicines or vaccines.
• Collaborate with Global Human Health (commercial) executive directors to inform of the GMSA portion of V&I plans to ensure alignment, while independently leading the execution of these plans.
• Organize global symposia and educational meetings.
• Support key countries with the development of local data generation study concepts and protocols when requested.
• Review Investigator‑Initiated Study proposals from key countries prior to headquarters submission (ex‑U.S.) and in collaboration with RDMAs, as well as serve as a review panel member on TA specific MISP’s to support the EDSA review process.
• Manage programs (patient support, educational or risk management) to support appropriate and safe utilization of Our Company medicines or vaccines.
• Demonstrate and champion our Ways of Working, emphasizing innovation, medical modernization, Hrvats team priorities, and focusing on the impact to the patient.
• Manage the assigned budget with strong financial stewardship, ensuring delivery within a 3% variance. Responsible and accountable for making informed decisions when budgets change throughout the year.

• M.D., Ph.D. or Pharm.
  
  D. (M.D. preferred) and recognized medical expertise
• Experience in country/region medical affairs or clinical development
• Strong prioritization and decision‑making skills
• Ability to effectively collaborate with partners across divisions in a matrix environment
• Excellent…